Publicaciones en colaboración con investigadores/as de University of Pavia (6)

2020

  1. Mechanistic Multiscale Pharmacokinetic Model for the Anticancer Drug 2’,2’-difluorodeoxycytidine (Gemcitabine) in Pancreatic Cancer

    Clinical and Translational Science, Vol. 13, Núm. 3, pp. 608-617

2017

  1. Model description language (MDL): A standard for modeling and simulation

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 6, Núm. 10, pp. 647-650

2015

  1. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

    Nature Communications, Vol. 6

  2. Pharmacometrics Markup Language (PharmML): Opening new perspectives for model exchange in drug development

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 4, Núm. 6, pp. 316-319

2014

  1. A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 3, Núm. 5

2010

  1. Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics

    European Journal of Cancer, Vol. 46, Núm. 1, pp. 21-32